Search This Blog

Sunday, August 30, 2026

United Therapeutics highlights new data supporting two FDA filings

 

United Therapeutics (UTHR) presents Phase 3 data on ralinepag and inhaled treprostinil at EU congresses, as FDA reviews PAH/IPF filings
https://seekingalpha.com/news/4638067-united-therapeutics-highlights-new-data-supporting-two-fda-filings
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)